日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study

SBT-020 在早期亨廷顿病患者中的安全性、药代动力学和药效学:一项分为两部分的研究

van Diemen, Marcus P J; Hart, Ellen P; Abbruscato, Anthony; Mead, Liz; van Beelen, Ilse; Bergheanu, Sandrin C; Hameeteman, Pieter W; Coppen, Emma; Winder, Jessica Y; Moerland, Matthijs; Kan, Hermien; van der Grond, Jeroen; Webb, Andrew; Roos, Raymund A C; Groeneveld, Geert Jan

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial

使用氨吡啶治疗多发性硬化症核间性眼肌麻痹:一项随机双盲、安慰剂对照交叉试验

Kanhai, Kawita M S; Nij Bijvank, Jenny A; Wagenaar, Yorick L; Klaassen, Erica S; Lim, KyoungSoo; Bergheanu, Sandrin C; Petzold, Axel; Verma, Ajay; Hesterman, Jacob; Wattjes, Mike P; Uitdehaag, Bernard M J; van Rijn, Laurentius J; Groeneveld, Geert Jan

Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatment

动脉粥样硬化的病理生理学和治疗:脂蛋白修饰治疗的现状与未来展望

Bergheanu, S C; Bodde, M C; Jukema, J W

Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction

急性心肌梗死患者的非对称二甲基精氨酸(ADMA)水平在早晨出现高峰。

Bergheanu, Sandrin C; van der Laarse, Arnoud; van der Bom, Johanna G; van der Hoeven, Bas L; le Cessie, Saskia; de Jong, Margreet G; Liem, Su-San; Schalij, Martin J; Jukema, J Wouter